Dashboard
Manage Tickers

RXRX RECURSION PHARMACEUTICALS, ...

Nasdaq recursion.com


$ 4.69 $ -0.29 (-5.82 %)    

Thursday, 06-Nov-2025 11:29:22 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.34 $ -8.51 (-1.37 %)
DIA $ 468.83 $ -3.23 (-0.68 %)
SPY $ 671.18 $ -5.30 (-0.78 %)
TLT $ 89.74 $ 0.18 (0.2 %)
GLD $ 366.36 $ -0.84 (-0.23 %)
$ 4.96
$ 4.99
$ 4.68 x 10,925
$ 4.69 x 5,740
$ 4.68 - $ 4.99
$ 3.79 - $ 12.36
57,423,883
na
2.58B
$ 2.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-05-2025 03-31-2025 10-Q
4 02-28-2025 01-01-1970 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-23-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-13-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

recursion-pharmaceuticals-q3-eps-036-misses-031-estimate-sales-5175m-miss-16983m-estimate
Recursion Pharmaceuticals Q3 EPS $(0.36) M...
11/05/2025 11:35:05

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.36) per share which missed the analyst consensus estim...

recursion-announces-ceo-transition-as-najat-khan-succeeds-co-founder-chris-gibson-to-lead-next-phase-of-techbio-growth
Recursion Announces CEO Transition As Naja...
11/05/2025 11:29:44

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

ww-international-replimune-group-datavault-ai-grail-and-other-big-stocks-moving-higher-on-monday
WW International, Replimune Group, Datavau...
10/20/2025 14:13:22

morgan-stanley-t1-energy-bunge-global-bank-of-america-and-other-big-stocks-moving-higher-on-wednesday
Morgan Stanley, T1 Energy, Bunge Global, B...
10/15/2025 14:47:54

costco-amd-recursion-pharmaceuticals-cipher-mining-and-snowflake-why-these-5-stocks-are-on-investors-radars-today
Costco, AMD, Recursion Pharmaceuticals, Ci...
10/09/2025 01:52:41

On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6...

whats-going-on-with-recursion-pharmaceuticals-stock-on-wednesday
What's Going On With Recursion Pharmaceuti...
10/08/2025 18:51:26

Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 ...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

dell-select-medical-century-aluminum-and-other-big-stocks-moving-higher-on-wednesday
Dell, Select Medical, Century Aluminum And...
10/08/2025 14:39:06

jim-cramer-says-this-financial-stock-is-a-total-spec-likes-dutch-bros
Jim Cramer Says This Financial Stock Is A ...
09/26/2025 12:36:12

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and...

what-analysts-are-saying-about-recursion-pharmaceuticals-stock
What Analysts Are Saying About Recursion P...
09/11/2025 13:00:34

needham-reiterates-buy-on-recursion-pharmaceuticals-maintains-8-price-target
Needham Reiterates Buy on Recursion Pharma...
09/11/2025 11:15:02

Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and maintains $8 price target.

recursion-pharmaceuticals-reports-wider-than-expected-q2-loss-beats-revenue-estimates
Recursion Pharmaceuticals Reports Wider-Th...
08/05/2025 16:08:07

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to Benzinga...

recursions-cash-position-as-of-june-30-2025-was-5338m-expected-to-extend-cash-runway-into-the-fourth-quarter-of-2027
Recursion's Cash Position As Of June 30, 2...
08/05/2025 10:35:49

recursion-pharmaceuticals-q2-2025-eps-041-misses-034-estimate-sales-19223m-beat-16233m-estimate
Recursion Pharmaceuticals Q2 2025 EPS $(0....
08/05/2025 10:31:08

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

recursion-pharmaceuticals-earnings-preview
Recursion Pharmaceuticals Earnings Preview
08/04/2025 17:05:12

palantir-nvidia--tempus-ai-could-be-pharma-etf-darlings-that-dont-make-pills
Palantir, Nvidia & Tempus AI Could Be Phar...
07/26/2025 12:31:39

Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still...

how-palantir-tempus-nvidia-backed-recursion-are-disrupting-big-pharma
How Palantir, Tempus, Nvidia-Backed Recurs...
07/25/2025 17:53:57

AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma...

top-2-health-care-stocks-you-may-want-to-dump-this-quarter
Top 2 Health Care Stocks You May Want To D...
07/22/2025 11:02:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION